Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IBEX (IBEX) EBITDA: 2022-2025

Historic EBITDA for IBEX (IBEX) over the last 3 years, with Sep 2025 value amounting to $8.6 million.

  • IBEX's EBITDA fell 7.06% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.8 million, marking a year-over-year increase of 8.51%. This contributed to the annual value of $38.4 million for FY2025, which is 19.93% up from last year.
  • IBEX's EBITDA amounted to $8.6 million in Q3 2025, which was down 11.37% from $9.8 million recorded in Q2 2025.
  • IBEX's EBITDA's 5-year high stood at $11.2 million during Q1 2025, with a 5-year trough of $4.2 million in Q2 2023.
  • Its 3-year average for EBITDA is $8.5 million, with a median of $8.6 million in 2025.
  • As far as peak fluctuations go, IBEX's EBITDA slumped by 32.80% in 2023, and later spiked by 104.29% in 2024.
  • IBEX's EBITDA (Quarterly) stood at $10.6 million in 2022, then crashed by 32.80% to $7.1 million in 2023, then increased by 14.20% to $8.2 million in 2024, then decreased by 7.06% to $8.6 million in 2025.
  • Its EBITDA stands at $8.6 million for Q3 2025, versus $9.8 million for Q2 2025 and $11.2 million for Q1 2025.